Reverse enhancement of hemorrhagic brain lesions on postcontrast MR: detection with digital image subtraction
- PMID: 8896621
- PMCID: PMC8338292
Reverse enhancement of hemorrhagic brain lesions on postcontrast MR: detection with digital image subtraction
Abstract
Purpose: To investigate the decrease in signal intensity on T1 - weighted MR images of some hemorrhagic intracranial lesions after administration of contrast material.
Methods: Postprocessing digital image subtraction was performed in 16 MR studies (13 patients) of lesions that showed hyperintensity on noncontrast T1-weighted images. Repetition time and echo time were identical for all precontrast and postcontrast studies. Regions of interest were measured in each lesion, contralateral white matter, and background (before and after contrast enhancement).
Results: In six of 16 MR studies, a significant net decrease in signal intensity was seen within the hemorrhagic lesion after contrast enhancement (reverse enhancement). All the lesions were hematomas within residual or recurrent malignant tumors.
Conclusions: Digital image subtraction confirms the existence of reverse enhancement. This phenomenon is due to the combined T2-shortening effects of two paramagnetic substances, methemoglobin and gadolinium, which cause the signal reduction produced by the T2 effects to occur at lower concentrations of gadolinium.
Similar articles
-
Optimizing brain MR imaging protocols with gadopentetate dimeglumine: enhancement of intracranial lesions on spin-density- and T2-weighted images.AJNR Am J Neuroradiol. 1991 Jul-Aug;12(4):675-9. AJNR Am J Neuroradiol. 1991. PMID: 1882743 Free PMC article.
-
Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine.AJNR Am J Neuroradiol. 1994 Sep;15(8):1425-34. AJNR Am J Neuroradiol. 1994. PMID: 7985559 Free PMC article.
-
Recurrent rectal cancer: diagnosis with dynamic MR imaging.Radiology. 1993 Dec;189(3):881-9. doi: 10.1148/radiology.189.3.8234720. Radiology. 1993. PMID: 8234720
-
Preliminary evaluation of fluid-attenuated inversion-recovery MR in the diagnosis of intracranial tumors.AJNR Am J Neuroradiol. 1996 Jun-Jul;17(6):1081-6. AJNR Am J Neuroradiol. 1996. PMID: 8791919 Free PMC article.
-
Optimal MR protocol for hepatic hemangiomas. Comparison of conventional spin-echo sequences with T2-weighted turbo spin-echo and serial gradient-echo (FLASH) sequences with gadolinium enhancement.Acta Radiol. 1997 Jul;38(4 Pt 1):565-71. doi: 10.1080/02841859709174388. Acta Radiol. 1997. PMID: 9240679
Cited by
-
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.Neuro Oncol. 2018 Aug 2;20(9):1240-1250. doi: 10.1093/neuonc/noy053. Neuro Oncol. 2018. PMID: 29660006 Free PMC article. Clinical Trial.
-
Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.Neurotherapeutics. 2017 Apr;14(2):307-320. doi: 10.1007/s13311-016-0507-6. Neurotherapeutics. 2017. PMID: 28108885 Free PMC article. Review.
-
Emerging techniques and technologies in brain tumor imaging.Neuro Oncol. 2014 Oct;16 Suppl 7(Suppl 7):vii12-23. doi: 10.1093/neuonc/nou221. Neuro Oncol. 2014. PMID: 25313234 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical